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Introduction: With the introduction of digital radiography, the feedback between image quality and over-
exposure has been partly lost which in some cases has led to a steady increase in dose. Over the years the
introduction of exposure index (EI) has been used to resolve this phenomenon referred to as ‘dose creep’.
Even though EI is often vendor specific it is always a related of the radiation exposure to the detector. Due
to the nature of this relationship EI can also be used as a patient dose indicator, however this is not
widely investigated in literature.
Methods: A total of 420 dose-area-product (DAP) and EI measurements were taken whilst varying kVp,
mAs and body habitus on two different anthropomorphic phantoms (pelvis and chest). Using linear
regression, the correlation between EI and DAP were examined. Additionally, two separate region of
interest (ROI) placements/per phantom where examined in order to research any effect on EI.
Results: When dividing the data into subsets, a strong correlation between EI and DAP was shown with
all R-squared values > 0.987. Comparison between the ROI placements showed a significant difference
between EIs for both placements.
Conclusion: This research shows a clear relationship between EI and radiation dose which is dependent
on a wide variety of factors such as ROI placement, body habitus. In addition, pathology and manufac-
turer specific EI’s are likely to be of influence as well.
Implications for practice: The combination of DAP and EI might be used as a patient dose indicator.
However, the influencing factors as mentioned in the conclusion should be considered and examined
before implementation.
© 2020 The College of Radiographers. Published by Elsevier Ltd. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Ever since the discovery of X-rays in 1895 by W.C. R€ontgen the
field of medical imaging has been in a state of constant develop-
ment. Of these developments the switch from analogue to digital
imaging has probably been the most impactful and has brought
numerous benefits. Of these benefits thewide dynamic range of the3, 9714 CA, Groningen,
stein).
shed by Elsevier Ltd. This is an open
The validity and reliability of
/j.radi.2020.03.012detectors introduced a new option for dose reduction, but para-
doxically introduced the concept of dose creep.1
Due to the wide dynamic range of most digital detectors,
modern systems are less likely to suffer from under- or over-
exposure. An increase in radiation dose results in less noise and
therefore a more ecstatically pleasing imaging, the initial intro-
duction of digital systems was followed by a gradual increase in
radiation dose, often referred to as ‘dose creep’. To help resolve the
issue of dose creep detector exposure indicators were introduced
by vendors.
Even though the introduction of exposure indicators has been
widespread, the use of vendor specific indicators has been shownaccess article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
the exposure index as ametric for estimating the radiation dose to the
Table 1
Parameters used (variables used for DAP validation highlighted using *).
Pelvis Chest
Tube voltage
(kVp)
Exposure time
product (mAs)
Tube voltage
(kVp)
Exposure time
product (mAs)
55* 10* 90* 0.8*
65 20 100 1.0
75* 32* 110* 1.2*
85 40 120 1.4
95* 50* 130* 1.6*
105 1.8
115 2.0
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push has been made for the development of a single Exposure In-
dex (EI).2 However, the use of EI as a patient dose indicator is still
not recommended.
Traditionally, patient dose from general radiography imaging is
often determined by using the dose area product (DAP) meter
mounted directly under the diaphragm. However, the inherent
dose dependent nature of the EI should have a relation with the
DAP, which implies a possible more intricate use for the EI in ra-
diation safety.
Several studies have shown the relationship between EI and the
entrance surface dose (ESD) under varying circumstances such as
exposure parameters, anatomy and body habitus.2,3 However,
limited research had been performed in order to validate the EI in
relation to the DAP under the combination of similar parameters.
The aim of this research project was to assess the validity and
reliability of using EI to estimate the DAP, and therefore patient
dose, when manipulating body habitus, exposure time product and
tube potential.
Methods
The studywas conducted in the School of Health& Society at the
University of Salford. A Wolverson Acroma Arco ceiling suspended
general X-ray system (Arcoma, Annav€agen, Sweden) with a retro-
fitted Konica Minolta DR unit (Konica Minolta Medical Imaging USA
INC, Wayne, NJ, USA) was used, which included a Cesium Iodide
(CsI) Aero image detector, was used for the data acquisition. The
built-in DAP meter of the Wolverson X-ray unit was used for the
acquisition and measurement of the DAP in mGy.cm2 in order to
estimate the patient ESD. Image acquisitionwas achieved using the
Konica Minolta CS7 software version 1.22R01_011. All equipment
used was part of a routine quality assurance test, that included
checks on tube output, tube potential, time consistency, tube po-
tential accuracy and linearity, all of whichwerewithin the expected
tolerances.
The study was performed using two adult chest and pelvis
anthropomorphic phantoms. The chest phantom used was the
adult multipurpose chest phantom N1 ‘LUNGMAN’, manufactured
by Kyoto Kagaku. The pelvis phantom used was an adult lower
sectional torso RS-113T manufactured by Radiology Support De-
vices. Both phantoms have an x-ray absorption very close to human
tissues and are anatomical representable of the average human
male as noted by both manufacturers. The chest and pelvis exam-
inations were chosen as they are amongst the most frequently
examined anatomical regions in general radiography.4 In addition,
both require different exposure factors which provides this
research with an additional approach regarding the EI e DAP
relation at different voltage and dose levels.
In order to assess the influence of body habitus on EI and DAP
two different body habitus were simulated by adding animal fat to
the anthropomorphic phantoms, following similar methods used in
previous research.5 The thickness of additional fat was chosen to
roughly simulate an overweight female as described by the NHS.6
This resulted in an addition of 2 cm to the chest phantom, and
10 cm of fat to the pelvis phantom.
Both phantoms were placed in AP position on the examination
table with the image detector in the Bucky tray with a non-
removable grid. The chest and pelvis phantoms were centered
and collimated following the guidelines described by Clark's
Radiographic Positioning.
Two millimeters of additional aluminum filtration were
included for the chest acquisitions, and 1mmAl with 0.1 mmCu for
the pelvis. This filtration was selected based on the clinical expe-
rience of the international research team conducting thePlease cite this article as: Erenstein HG et al., The validity and reliability of
patient, Radiography, https://doi.org/10.1016/j.radi.2020.03.012experiment. In order to ensure stable exposures, the exposure time
product was inputtedmanually, no automatic exposure control was
used.
In addition to the effect of body habitus and exposure time
product the influence of tube voltage (kVp) was investigated. These
parameters were chosen because both tube voltage and exposure
time product can have a significant influence on patient and de-
tector dose. The exposure time product and voltage variations were
chosen to assess the influence of these across a broad spectrum of
acquisition parameters, as shown in Table 1. Patient habitus was
included as its effect on EI has not beenwidely investigated. All the
variations in tube voltage, exposure time product and body habitus
resulted in 420 data points.
In order to minimize the influence of other parameters the
collimation (as described), SID (120 cm), focus (large), grid and
post-processing parameters were kept constant, all of which were
chosen to represent clinical practice.
To validate the reliability of the DAP meter, five measurements
were taken with low, medium and high exposures, for each of the
anatomical areas (marked in Table 1 using *). The mean values and
relative standard deviations were calculated in order to affirm the
DAP reliability and validity.
EI measurements were performed using two region of interests
(ROI), drawn using the DR workstation. The first measurement
covered the entire irradiated area (Fig. 1A, C) and the second
covered a reproducible part of anatomy of both areas to ensure
consistency (Fig. 1B, D). This second set of measurements was ac-
quired to investigate the influence of the ROI placement on the
resultant EI value. The chest included the entire lung fields for the
second ROI measurement, whereas the pelvis was set to include
both femoral heads and iliac fossa.
The entire data set was analysed using SPSS Version 25.0 (IBM
Inc, Armonk, NY). The significance between the different ROI
placements was assessed using the Wilcoxon signed-rank test.
The correlation between EI and DAP for the entire data was
calculated using linear regression expressed using R-squared. In
addition to the whole dataset, several subsets were analysed (e.g.
body habitus, anatomical region (chest & pelvis) and different tube
voltages).Results
Before the data acquisition, DAP validation was performed for
both the chest and pelvis phantom. Three exposures were tested,
ranging from low to high exposures, for both the chest and pelvis as
mentioned in Table 1. For the low chest exposures, the average DAP
was 22.4 mGy cm2 with a relative standard deviation of ± 2.5%. For
the medium exposure of the chest, the average DAP was 55.4 mGy
cm2 with a relative standard deviation of ± 1.0% and for the high
exposure an average DAP of 102 mGy cm2 was measured with a
relative standard deviation of ±0.7%. Regarding the pelvisthe exposure index as ametric for estimating the radiation dose to the
Figure 1. Different ROI placements, A & C show the ROI placed over the whole irradiated area, whilst B & D show the ROI places over the anatomic area.
H.G. Erenstein et al. / Radiography xxx (xxxx) xxx 3exposures the resulted average measured DAPs and relative stan-
dard deviations were 86.6 mGy cm2 ( ± 0.6%), 667 mGy cm2
( ± 0.1%) and 1800 mGy cm2 ( ± 0.1%), respectively.
The total number of exposures resulted in a dataset consisting
of 420 points consisting of DAP and both ROI placements. One
deviating measurement (0.2% of the total measurements) was
discovered in the pelvis dataset at 80 kVp and 10 mAs with an EI
of 199.60 where other two of three exposure measurements areFigure 2. EI vs DAP for all data points on Chest (left, R-squared 0.887) and Pelvis (right, R-squ
references to color in this figure legend, the reader is referred to the Web version of this a
Please cite this article as: Erenstein HG et al., The validity and reliability of
patient, Radiography, https://doi.org/10.1016/j.radi.2020.03.012120.1, this was most likely an error in notation but other causes
could not be excluded. Because of the minor nature in relation to
the complete dataset and the lack of a clear explanation it was not
excluded.
A Wilcoxon-signed rank test between the two ROI placement
situations showed a significant difference in EI between both sets
(P < 0.05). As there was a significant difference separate regression
analysis were performed for both datasets.ared 0.554) phantoms both without fat (blue) and with (red). (For interpretation of the
rticle.)
the exposure index as ametric for estimating the radiation dose to the
Figure 3. EI as a variable of the DAP categorised by the kVp on a Pelvis without Fat added measured by using a ROI placement over the whole irradiated area.
Figure 4. Regression coefficient as a function of tube voltage for all chest phantom subsets.
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When the set is divided between non-fat and fat it shows an R-
squared of 0.866 for non-fat and R-squared of 0.411 for fat. Dividing
the set into anatomical regions it shows an R-squared of 0.887 for
the chest and an R-squared of 0.554 for the pelvis as shown in Fig. 2.
When dividing the whole dataset into anatomic regions, body
habitus and ROI placements, this resulted in a total of eight subsets.
These eight subsets can be further divided into tube voltage. All
eight R-squared values are above 0.987, showing a strong correla-
tion between EI and DAP this is visually represented in Fig. 3.
For all the eight subsets the regression coefficient per data
subset are plotted against the tube voltage as shown in Figs. 4 and 5.
Discussion
The research study was performed to validate the relationship
between EI and DAP. The results show that it is possible to estimate
the DAP, and with that the patient dose, based on a given EI value.
However, the linear relationship between EI and DAP is dependent
on multiple variables, of which body habitus is the most influential.
This is clearly expressed by the R-squared values within the
various data subsets of anatomical region and body habitus. The R-
squared of the entire data set, the correlation between EI and DAP is
moderate (0.506). Once the data is separated, the effect of body
habitus on the EI values is clearly demonstrated because the cor-
relation without additional fat is very strong (0.866) as opposed to
the weak correlation (0.411) when additional fat is added in two
different thicknesses per anatomical region. This is significant
because the patient dose can be estimated using EI but patient
habitus must be taken into consideration. Depending on the known
variables, DAP and EI can be estimated relatively simply, using the
appropriate slope resultant from regression.Figure 5. Regression coefficient as a function of
Please cite this article as: Erenstein HG et al., The validity and reliability of
patient, Radiography, https://doi.org/10.1016/j.radi.2020.03.012Previous studies substantiate these findings, as a strong rela-
tionship has been proven between EI and ESD (R-squared value of
0.67), suggesting that EI can be used for estimating absorbed pa-
tient dose.3 However, literature suggests that EI values still differ
from manufacturer to manufacturer, this lack of a universal EI
provides further concern in the implementation of EI as a dose
indicator.7 Therefore, before using the EI as a dose indicator, ex-
periments and further research should be performed on various
other DR systems since only a Konica Minolta CS7 system was
tested in this study. It should be noted that Konica Minolta CS7
implements the IEC62494-1 in order to calculate the EI, a linear
approach which is common for other vendors as well.
This study has considered three different factors in order to
further investigate the relationship between EI and DAP.
Compared to other studies, which changed one factor when
investigating this relationship and used other anatomical areas of
interest, for example the knee.8 Though a linear relationship was
proved in the current study between the EI and DAP for both the
pelvis and chest, the results are likely to be applicable for other
anatomical regions too.
In addition to the three included variables in this research was
focused on the DAP measurements compared to the ESD in other
studies. The DAP was chosen as the preferred measurement
because measuring the ESD would require the placement of a
dosimeter over the anatomical area of interest. Such a modifica-
tion to the study protocol would likely influence the EI value, as
there would be an electronic component within the resultant
image. Additionally, the use of the DAP is widely implemented in
patient dose legislation regarding the diagnostic reference levels
(DRL's).4,9
One important note should be placed on pathology. The
anthropomorphic phantoms gave a representation of the humantube voltage for all pelvis phantom subsets.
the exposure index as ametric for estimating the radiation dose to the
H.G. Erenstein et al. / Radiography xxx (xxxx) xxx6anatomy but lacked in representing different pathologies and
anatomies and therefor the effect it may have on EI.2 Previous
studies have shown that the EI values may vary for different pa-
thologies and because of this should be consideredwhen aiming for
optimal EI values.2
Any practical implementation of EI as a dose indicator is not only
limited by the effect of pathology but also by ROI placement. This
study has shown the position of the ROI is of influence on the EI in
this system, therefore ROI placement for EI measurements should
be placed using clear definitions if the system used determines the
EI within a given ROI. Please note that there are vendors which
supply systems which determine the EI from the whole detector
instead of within a given ROI. In addition to this any differences in
anatomy, pathology or patient positioning could influence the
measurements within a determined ROI. Finally the variation in
collimation and SID in practice will influence both the values and
relationship between the EI and DAP, this should be taken into
account.
In view of the linear relation between EI and DAP there is likely
to be an equal relationship between EI and exit dose within the
exposure parameters used. Given this, a possible future imple-
mentation of EI as a dose indicator could involve the EI as an exit
dose indicator. This, in combination with the ESD calculated from
DAP could be used to estimate the absorbed patient dose from in-
formation available in the DICOM-header.
Conclusion
This study has shown the feasibility of using EI as a dose indi-
cator, however before clinical implementation, it is important that
the influence of other factors on the EI values are investigated more
thoroughly. These factors include a wider range of body habitus,
ROI positioning, differences between manufacturers’ technology,
variations in anatomy and the presence of pathology.
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